LITT for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk …

Hassan Fadel

Dr. Ted Diethrich's Enduring Trajectory Changing Gift - The Blueprint

Transformative Endovascular Decisions Conference

C. Dall’Olmo

Role of the Society of Interventional Oncology

Symposium on Clinical Interventional Oncology (CIO 2018)

S. Solomon

How the Neurosurgeon Uniquely Meets the Unmet Need in Today's Precis…

Subcortical Surgery Group

H. Brem

Glioblastoma: How Aggressive to Be?

Ricardo Komotar

Are Office-Based Procedures Safe? Ready for Prime Time?

Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

R. Zakir

Congenital Neoplasms: Rare, Unique and Poorly Described

UChicago Medicine

L. Baird

Penn Medicine Updates on Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Overview and Updates in Brain Tumors

Henry Friedman

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

Primary Brain Tumors: Targeting Metabolism in Glioma

UNC Lineberger Comprehensive Cancer Center

D. Higgins

Updates on Glioblastoma

Dana-Farber Cancer Institute

D. Reardon

MIPS in Tumor Applications: Deep Brain Lesions a Review of Current S…

Subcortical Surgery Group

K. Chaichana

GBM Clinical Trials: Early Observations and Future Directions

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. O'Rourke

The Sunshine Act - Understanding the Ins and Outs

Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

S. Noor

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

New Advances in Minimally Invasive Brain Surgery: What You Need to K…

2020 South Florida Neuroscience Symposium

R. Komotar

Private Practice vs. Hospital Employment A Tough Choice

Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

C. Haery

Why 5-ALA Fluorescence-Guided Surgery (FGS) for Brain Tumors?

Mount Sinai Fluorescence-Guided Surgery Symposium

C. Hadjipanayis